A groundbreaking annual injection designed to protect against HIV has successfully passed its first safety trial, bringing new hope for long-term prevention.

Up to 80 percent of Uganda’s HIV/Aids response is funded by external donors such as the US government and the Global Fund. The funds have been covering majorly the purchase of antiretroviral ...

At the tender age of seven, in the year 2008, Gigi (not her real name) experienced the heart-wrenching loss of her father to HIV/Aids. Left behind were Gigi, her sister and her brother, placing their ...

Africa’s over 1 billion people account for 95% of the estimated malaria deaths worldwide, according to the World Health ...

Child rights experts have raised concerns that despite advancements in Uganda's legal and policy frameworks, the country's investment in crucial social sectors such as education, health, nutrition, ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

USAID was the pace-setter on locally led development," says Moses Isooba of the Uganda National NGO Forum. But now that it ...

KAMPALA, Uganda (AP) — Aid cuts by the United States are hurting Africa’s capacity to respond to disease outbreaks, the head ...

The university, a leader in scientific research, has been hard hit by the Trump administration’s cuts, which will slash at ...

For six weeks now, Elizabeth Tembo (not real name) from Zingwangwa Township in Blantyre has not gone for viral load testing due to suspension of the services in public health facilities. She used to ...